| Ytd | -11.59% | |
| 1y | -22.46% |
| Open | 21.07 | Prev Close | 20.88 | Low | 20.91 | High | 21.24 | Mkt Cap | 11.21B |
| Vol | 1.01M | Avg Vol | 756.94K | EPS | 1.95 | P/E | 10.80 | Forward P/E | 7.05 |
| Beta | 0.81 | Short Ratio | 4.46 | Inst. Own | 9.86% | Dividend | 0.87 | Div Yield | 4.17 |
| Ex Div Date | 05-22 | Earning | 11-03 | 50-d Avg | 23.07 | 200-d Avg | 22.99 | 1yr Est | 23.99 |
FMS' transformation is lifting profitability, while HDF, value-based care and cost savings offset vo
Fresenius Medical Care (FME), the world's leading provider of products and services for individu
FMS refines its China strategy around advanced dialysis and critical-care technologies, with 110M eu
Fresenius Medical Care AG and Co. KGaA (NYSE: FMS - Get Free Report) has received an average recomme
Fresenius Medical Care updates China strategy, and incurs a 110 million euro charge while focusing o
Fresenius Medical Care has operated in China for more than two decades. The market represents approx
Refinements support the Company's China go-to-market and commercial strategy in an important and gro
Tidal Investments LLC grew its stake in shares of Fresenius Medical Care AG and Co. KGaA (NYSE: FMS)
FDA warns Fresenius over Utah plant violations, citing leaking dialysis bags and visual inspection f
Fresenius Medical is scaling its 5008X rollout across U.S. clinics, creating growth potential despit
Fresenius Medical's improving profitability, 5008X rollout and value-based care gains offer support
Fresenius Medical Care (FME), the world's leading provider of products and services for individu
Fresenius Medical Care AG and Co. KGaA (NYSE: FMS - Get Free Report) shares passed above its two hun
These stocks have economic moats and look attractive today.
Bernstein analyst Lisa Clive maintains Fresenius Medical Care (NYSE:FMS) with a Market Perform an
Fresenius Medical Care AG and Co. KGaA (NYSE: FMS) reported second-quarter 2026 organic revenue grow
FMS posts 28% EPS growth as Care Delivery profitability and margin gains offset a quarterly revenue
Silicon Motion Technology Corporation (NasdaqGS: SIMO) (âSilicon Motionâ), a global leader in de
TAIPEI, Taiwan--(BUSINESS WIRE)-- #AIStorage--Silicon Motion Technology Corporation (NasdaqGS: SIMO)
Fresenius Medical Care AG (FMS) Q2 2026 Earnings Call Transcript
Fresenius Medical Care (NYSE:FMS) held its second-quarter earnings conference call on Tuesday. Below
U.S. stock futures rise on Tuesday, but Powell Industries Inc shares fall 13.4% after reporting lowe
Fresenius Medical Care AG & Co. KGaA NYSE: FMS reported second-quarter 2026 organic revenue growth o
Shares fell, wiping out most of their gains since the start of the year, after the German dialysis s
Fresenius Medical Care (NYSE:FMS) affirms FY2026 sales outlook from $23.764 billion to $23.764 billi
TOKYO--(BUSINESS WIRE)--Kioxia will showcase the innovations driving the performance, scalability, a
Fresenius Medical Care shares fell in early trade on Tuesday, as investors looked past a second-quar
Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.66 per share which beat the anal
Fresenius Medical Care on Monday reported second-quarter operating income well ahead of market expe
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $MRVL #AI--Marvell Technology, Inc. (NASDAQ: MRVL), a leade
Fresenius Medical Care (FME), the world's leading provider of products and services for individu
Fresenius Medical Care (NYSE:FMS) affirms FY2026 sales outlook from $23.764 billion to $23.764 billi
Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.53 per share which missed the an
Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.84 per share which beat the anal
Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.64 per share which beat the anal
Fresenius Medical Care invests EUR 312 million and successfully closes a share purchase agreement wi
FDA approves Amphastar's iron sucrose injection for CKD-associated anemia, with potential for $8
Outlook 2025 confirmedFresenius Medical Care confirms its outlook for fiscal 2025 and expects revenu
Azenta, Inc. (NASDAQ:AZTA) today announced that it has entered a collaboration with Frenova, a divis
Frenova and Nephronomics, a renal precision company co-founded by Fresenius Medical Care, initiate c